MIMEDX Confirms Fourth Quarter and Full Year 2022 Net Sales Expectations, Comments on Evolving Medicare Reimbursement Landscape and Provides Corporate Updates

January 9, 2023

https://www.globenewswire.com/news-release/2023/01/09/2585209/0/en/MIMEDX-Confirms-Fourth-Quarter-and-Full-Year-2022-Net-Sales-Expectations-Comments-on-Evolving-Medicare-Reimbursement-Landscape-and-Provides-Corporate-Updates.html

Fourth quarter and full year 2022 net sales expected in the ranges of $73 million to $76 million and $266 million to $269 million, respectively

Provides commentary regarding the potential impact of recently published Medicare reimbursement proposals on its wound care products

Read more at globenewswire.com

Related news for (MDXG)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.